Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy
Andrei Iordache, Ana Maria Bugă, Dana Maria Albulescu, Ramona Constantina Vasile, Radu Mitruţ, George S. Georgiadis, Ioannis-Erineos Zisis, Charalampos Mamoulakis, Aristidis Tsatsakis, Anca Oana Docea, Daniela Călina
Topics & Concepts
TadalafilSildenafilcGMP-specific phosphodiesterase type 5Contrast-induced nephropathyKidneyH&E stainMedicineNitric oxideNephropathyChemistryPharmacologyInternal medicineEndocrinologyImmunohistochemistryDiabetes mellitusAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesRenal and Vascular Pathologies